|
What's Your Weight Loss Gene? (ThirdAge)
Is that low-carb diet not working for you? Or is it the low-fat diet that's not taking off those pounds. It may just be your genes. That's the pitch behind a new test that claims to show whether people will do better on a low-fat or a low-carb weight loss plan.
(Mar 8, 2010)
New facility links protein studies to U. (The Daily Targum)
By: Greg Flynn Through a large renovation project, the Center for Integrative Proteomics Technologies is aspiring to unify and strengthen separate strands of protein research currently isolated within University departments. Construction to the $47 million center began ...
(Mar 9, 2010)
454 Life Sciences, Roche Diagnostics, Keygene, Cold Spring Harbor Laboratory Press, W.H. Freeman and Company (GenomeWeb News)
454 Life Sciences said this week that it has shipped its new high-throughput Genome Sequencer FLX system to its marketing partner Roche Diagnostics in preparation for a launch later this quarter.
(Mar 9, 2010)
Recent NIH Awards in Proteomics to Companies in FY 2004 (GenomeWeb News)
Christopher Maher is focused on elucidating gene fusions, which he first became acquainted with during his potdoctoral work at the Michigan Center for Translational Pathology. Maher hopes to continue discovering novel gene fusions as well as draw new findings out of already-known gene fusions.
(Mar 9, 2010)
NIH Issues Three RNAi-Related Grants, Announces Projects With RNAi Potential (GenomeWeb News)
The National Institutes of Health this month issued three grants funding RNAi-related research in cancer including one involving the development of shRNA vectors to study transcription factors associated with tumorigenesis, one examining whether RNAi can be used to suppress a protein linked to leukemia, and one looking at the roles certain microRNAs play in lymphomas.
(Mar 9, 2010)
New joint doctoral programs (The Daily Aztec)
By: Janel Bruan, Contributor San Diego State is classified as a doctoral research university, and for a good reason. Evolutionary biology and geophysics have joined the ranks as two new joint doctoral programs after being approved late last month. It’s been 50 years since the c...
(Mar 9, 2010)
A Vision for Personalized Medicine (Technology Review)
Genomics pioneer Leroy Hood says a coming revolution in medicine will bring enormous new opportunities. Leroy Hood has been at the center of a number of paradigm shifts in biology. He helped to invent the first automated DNA sequencing machine in the 1980s, along with several other technologies that have changed the face of molecular biology. And in 2000, he founded the Institute for Systems ...
(Mar 9, 2010)
RDS launches international outreach program focusing on cognitive impairment in individuals with Down syndrome (News-Medical-Net)
Research Down Syndrome has launched an international outreach program to focus awareness and support for the rapidly advancing area of biomedical research leading to safe and effective approved medical therapies to treat cognitive impairment in individuals of all ages with Down syndrome -- improving memory, learning and communication.
(Mar 9, 2010)
Gene test claims to show what diet works best (GMA News)
Diet not working? Blame your genes. That's the pitch behind a new test that claims to show whether people will do better on a low-fat or a low-carb weight loss plan.
(Mar 9, 2010)
PAF launches resource directory to assist underinsured consumers (News-Medical-Net)
Patient Advocate Foundation (PAF) – a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases – with the Patient Action Council Delegates, unveiled The National Underinsured Resource ...
(Mar 9, 2010)
USF study: HHV-6 causes permanent infection by inserting its DNA into human chromosomes (News-Medical-Net)
Human herpesvirus 6 (HHV-6) infects nearly 100 percent of humans in early childhood, and the infection then lasts for the rest of a person's life. Now, a team led by Peter Medveczky, MD, a professor in the Department of Molecular Medicine at the University of South Florida, has discovered that in some individuals, HHV-6 causes such a permanent infection by inserting or "integrating" its DNA into ...
(Mar 9, 2010)
The Side-Out Foundation Hopes to Score Big with Its First Funded Breast Cancer Clinical Trial (PR Newswire via Yahoo! News)
SCOTTSDALE, Ariz. and FAIRFAX, Va., March 9 /PRNewswire-USNewswire/ -- The Side-Out Foundation, which pairs volleyball enthusiasts with breast cancer researchers, is sponsoring a new clinical trial for up to 25 patients with advanced breast cancer.
(Mar 9, 2010)
Promega - TOP srl Agreement Enables Live Animal Imaging for Cancer Studies (Business Wire via Yahoo! Finance)
MADISON, Wis.----Promega and TOP srl have combined their industry leading technologies to provide the most sensitive tools for monitoring apoptosis in live mammals, an important biomarker in cancer studies.
(Mar 9, 2010)
Bio-Synthesis Awarded NIH Grant to Develop Synergistic Adjuvants that Stimulate both Innate and Adaptive Immunities (PR.com)
BioSynthesis announces the award of a two-year phase I SBIR grant by NIH to further its development program of immune agonists. These new agents have in their chemical structure different determinants that stimulate both innate and acquired immunity, leading to synergistic effects on the immune response. These new immune agonists could be useful in the development of difficult vaccines such as ...
(Mar 9, 2010)
Rosetta Genomics to Present at the 22nd Annual Roth OC Growth Stock Conference (Business Wire via Yahoo! Finance)
PHILADELPHIA & REHOVOT, Israel----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, announced that Kenneth A. Berlin, president and chief executive officer, will be presenting a corporate update at the 22nd Annual Roth OC Growth Stock Conference on Tuesday, March 16, 2010 at 3:30 p.m. at the Ritz Carlton Laguna Niguel in Dana Point, California.
(Mar 9, 2010)
When Should You Sell? (The Motley Fool)
The Fool's newest advisor, Tom Jacobs, takes on his former mentor, Fool co-founder David Gardner, on how to sell smart.
(Mar 9, 2010)
New Approach To Immune Cell Analysis Seen As First Step To Better Distinguish Health And Disease (Medical News Today)
Investigators have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human whole blood, and has the potential to distinguish between health and disease states. Led by Mark Davis, Ph.D., and Atul Butte, M.D., Ph.D., of Stanford ...
(Mar 9, 2010)
NCI, ESTools License Integromics Software (GenomeWeb News)
NEW YORK (GenomeWeb News) – Integromics said today that the National Cancer Institute and the ESTools consortium, a European stem cell research organization, have purchased site-wide licenses for its RealTime StatMiner data analysis software solution.
(Mar 9, 2010)
A New Approach to Immune Cell Analysis (GenomeWeb News)
Researchers at Stanford University have come up with a new approach to analyzing immune cells that identifies changes in small samples of human whole blood, and has the potential to distinguish between health and disease states.
(Mar 9, 2010)
New Product Watch (GenomeWeb News)
Fluidigm this week launched 5-kilobase and 10-kilobase long-range PCR protocols for its Access Array System . Access Array, launched last year, enables users to amplify up to 48 samples per array for use in targeted resequencing applications.
(Mar 9, 2010)
Researchers Identify Previously Unrecognized Genetic Disorder (Business Wire via Yahoo! Finance)
SPOKANE, Wash.----Researchers from four laboratories that perform diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities recently identified a previously unrecognized genetic disorder.
(Mar 9, 2010)
Press Release (PharmiWeb)
Rosetta Genomics Ltd. Posted on:09 Mar 10 Rosetta Genomics, Ltd. (NASDAQ: ROSG) , a leading developer of microRNA-based molecular diagnostics, announced that Kenneth A. Berlin, president and chief executive officer, will be presenting a corporate update at the 22nd Annual Roth OC Growth Stock Conference on Tuesday, March 16, 2010 at 3:30 p.m. (Pacific Time) at the Ritz Carlton Laguna Niguel in ...
(Mar 9, 2010)
Chemical competition: Research identifies new mechanism regulating embryonic development (Science Daily)
A research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
(Mar 9, 2010)
New Mechanism Regulating Embryonic Development Identified (redOrbit)
Image Caption: The Princeton team used confocal microscopy to visualize the spatial distribution of two proteins that compete for the MAPK enzyme in early fruit fly embryos. In areas where levels of a protein important for the development of the head were high (shown here in red, with brighter color indicating the presence of more protein) there was less enzyme available to act upon a different ...
(Mar 9, 2010)
GenomeQuest Opens API for Sequence Data Management (dBusinessNews.com)
Cambridge, MA — At a gathering of life science researchers, bioinformatics developers, and computational biologists, GenomeQuest today announced a comprehensive Application Programming Interface (API) to its fast-growing sequence data management (SDM) platform.
(Mar 9, 2010)
ExonHit, BioMerieux Kill Colon Cancer Program, Continue to Develop Prostate Cancer Dxs (GenomeWeb News)
ExonHit Therapeutics and BioMérieux this week said they will discontinue co-developing biomarkers related to colon cancer, but will continue to develop markers for prostate cancer.
(Mar 9, 2010)
Refocusing on Product Sales, Gentel Bio Debuts Proteomic Platform (GenomeWeb News)
Gentel Biosciences, a long-time custom assay and services shop, has expanded its business model by launching a new proteomic platform as a way to enable customers to process samples in their own lab.
(Mar 9, 2010)
Mathematical approach to immune cell analysis seen as first step to better distinguish health and disease (Science Daily)
Researchers have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human whole blood, and has the potential to distinguish between health and disease states.
(Mar 9, 2010)
Monsanto Expands (Zacks.com via Yahoo! Finance)
Monsanto completed its $200 million expansion just outside of New Orleans.
(Mar 9, 2010)
Cytogenetics Labs ID New Genetic Disorder by Array CGH (GenomeWeb News)
Four US laboratories that perform diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities have used microarray-based comparative genomic hybridization to identify a previously unrecognized genetic disorder.
(Mar 9, 2010)
NCI-CPTC, AACC Agreement Aims to Advance Proteomics in Clinical Labs (GenomeWeb News)
In another step aimed at intertwining clinical chemistry more closely with clinical proteomics, the National Cancer Institute's proteomics program and the American Association of Clinical Chemistry have entered into a memorandum of understanding to co-promote proteomics technologies and standards in the clinical chemistry community.
(Mar 9, 2010)
Genomics Illuminates a Deadly Brain Cancer [Medical News & Perspectives] (Journal of the American Medical Association)
JAMA. 2010;303(10):925-927. Scientists have long been stymied in their efforts to develop effective treatments for glioblastoma multiforme, a rapidly growing cancer of the brain that patients rarely survive much longer than a year.
(Mar 9, 2010)
At AGBT, Complete Genomics Sketches Route to 1M Human Genomes; Discusses Early Customer Projects (GenomeWeb News)
Complete Genomics recently described a number of planned technical improvements to its proprietary large-scale sequencing platform that will allow it to sequence 100,000 human genomes per year on 20 sequencing instruments in a single sequencing facility.
(Mar 9, 2010)
New Products (GenomeWeb News)
Fluidigm has released 5-kilobase and 10-kilobase long-range PCR protocols for its Access Array system, which allows users to amplify up to 48 samples per array for use in targeted resequencing.
(Mar 9, 2010)
PacBio Takes Top Spot, Complete Genomics Ranks Seventh Among VentureSource's Top 50 VC-Backed Companies (GenomeWeb News)
Pacific Biosciences took first place and Complete Genomics came in seventh in a recent ranking of venture-backed companies by research firm VentureSource.
(Mar 9, 2010)
PacBio Takes Top Spot, Complete Genomics Ranks Seventh Among VentureSource's Top 50 VC-Backed Firms (GenomeWeb News)
Pacific Biosciences took first place and Complete Genomics came in seventh in a recent ranking of venture-backed companies by research firm VentureSource.
(Mar 9, 2010)
Clinical Trial Using Proteomics Technologies for Personalized Medicine Approach to Breast Cancer (GenomeWeb News)
A new clinical trial is using proteomics technologies to help guide doctors to make personalized treatment regimens for patients with breast cancer.
(Mar 9, 2010)
Sonic hedgehog gene found in an unexpected place during limb development (EurekAlert!)
( University of Florida ) Sonic hedgehog is at work in mice limb buds in what is known as the ectoderm, the cell layer that gives rise to skin, researchers discovered. Finding Sonic hedgehog here is akin to discovering that yeast has crept from the batter to the frosting, where it has the surprising effect of limiting how much the cake rises. In this case, instead of causing appendages to grow ...
(Mar 9, 2010)
Life Tech, TGen, US Oncology to Partner on Breast Cancer Sequencing Study Aimed at Therapy Advice (GenomeWeb News)
Life Technologies, the Translational Genomics Research Institute, and US Oncology said last week that they are collaborating to sequence 14 breast cancer tumors using Life Tech's SOLiD system in order to help with treatment decisions.
(Mar 9, 2010)
Evolutionary genetic relationships coming into focus (Science News)
With the evolutionary tree of life nearly half done for birds and mammals, other vertebrates lag behind
(Mar 9, 2010)
Sonic hedgehog gene found in an unexpected place during limb development (PhysOrg)
Sonic hedgehog, a gene that plays a crucial rule in the positioning and growth of limbs, fingers and toes, has been confirmed in an unexpected place in the embryos of developing mice -- the layer of cells that creates the skin.
(Mar 9, 2010)
Cellzome Lands Big GSK Deal: 475M for Inflammatory Diseases (BioWorld)
LONDON - Cellzome Ltd. signed its second big deal with GlaxoSmithKline plc, agreeing on a €475 million (US$644.3 million) collaboration to apply its epigenetics platform technology in the discovery of oral small-molecule drugs for treating immuno-inflammatory diseases.
(Mar 9, 2010)
Integromics Inks Two Licenses, Training Agreement for qPCR Analysis Software (GenomeWeb News)
Spanish bioinformatics firm Integromics in the past week inked three agreements expected to increase the number of users of RealTime StatMiner, its real-time quantitative PCR data-analysis tool.
(Mar 10, 2010)
Fraser-Liggett to Start New Genomics Institute at UMB Biopark (GenomeWeb News)
NEW YORK (GenomeWeb News) — Claire Fraser-Liggett will start and lead a new genomics institute at the University of Maryland School of Medicine in Baltimore, the school said today.
(Mar 10, 2010)
Obese patients with colon cancer are at greater risk for death (News-Medical-Net)
Obese patients with colon cancer are at greater risk for death or recurrent disease compared to those who are within a normal weight range, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
(Mar 10, 2010)
Side-Out Foundation sponsors new advanced breast cancer clinical trial (News-Medical-Net)
The Side-Out Foundation, which pairs volleyball enthusiasts with breast cancer researchers, is sponsoring a new clinical trial for up to 25 patients with advanced breast cancer.
(Mar 10, 2010)
Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease (PR Newswire via Yahoo! Finance)
Leading Proteomics Technology in Epigenetics
(Mar 10, 2010)
BUSINESS WIRE: Austrian Biomarker Expert BIOCRATES Life Sciences AG and Canadian CHENOMX Inc Sign Co-Marketing Agreement (vwd.de)
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.
(Mar 10, 2010)
Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease (redOrbit)
Collaboration Exploits Cellzome's World-Leading Proteomics Technology in Epigenetics CAMBRIDGE, England and HEIDELBERG, Germany, March 10, 2010 /PRNewswire/ -- Cellzome today announced that it has formed a second strategic alliance with GlaxoSmithKline (GSK).
(Mar 10, 2010)
Sonic hedgehog gene also at work in the ectoderm (News-Medical-Net)
Sonic hedgehog, a gene that plays a crucial rule in the positioning and growth of limbs, fingers and toes, has been confirmed in an unexpected place in the embryos of developing mice - the layer of cells that creates the skin.
(Mar 10, 2010)
|
